Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Aafke R. Koffeman"'
Autor:
Jacoline J. Driest, Dieuwke Schiphof, Aafke R. Koffeman, Marc A. Koopmanschap, Patrick J. E. Bindels, Sita M. A. Bierma‐Zeinstra
Publikováno v:
ARTHRITIS & RHEUMATOLOGY, 74(5), 818-828. John Wiley & Sons Ltd.
Objective: To assess the effectiveness of duloxetine in addition to usual care in patients with chronic osteoarthritis (OA) pain. The cost-effectiveness and whether the presence of symptoms of centralized pain alters the response to duloxetine were s
Autor:
Jacoline J. van den Driest, Dieuwke Schiphof, Patrick J. E. Bindels, Aafke R. Koffeman, Marc A. Koopmanschap, Sita M. A. Bierma‐Zeinstra
Publikováno v:
Arthritis and Rheumatology, 74(11), 1860-1861. John Wiley & Sons Ltd.
Autor:
Hein J.E.M. Janssens, Marloes L Jacobs, Johan van der Lei, Kevin D. B. van Leeuwen, Sita M A Bierma-Zeinstra, Aafke R Koffeman, Patrick J E Bindels, Arthur M. Bohnen
Publikováno v:
BMJ Open
BMJ Open, 8(11):e024335. BMJ Publishing Group
BMJ Open, 8
BMJ Open, 8, 11
BMJ Open, 8(11):e024335. BMJ Publishing Group
BMJ Open, 8
BMJ Open, 8, 11
IntroductionGout is the most common inflammatory arthritis in the Dutch general practice population and is often managed with long-term uric acid lowering treatment. The clinical relevance of this treatment in preventing gout attacks is unclear.Prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36434d7ec0ccb8b568cb5fc4cd24db2
https://doi.org/10.1136/bmjopen-2018-024335
https://doi.org/10.1136/bmjopen-2018-024335
Autor:
Peter A. G. M. De Smet, Geert W. ‘t Jong, Miriam C. J. M. Sturkenboom, Vera E. Valkhoff, Cornelis Kramers, Margaretha F. Warlé-van Herwaarden, Aafke R Koffeman
Publikováno v:
British Journal of Clinical Pharmacology. 80:589-598
textabstractAims Low-dose aspirin (LDA) and non-steroidal-anti-inflammatory drugs (NSAIDs) both increase the risk of upper gastrointestinal events (UGIEs). In the Netherlands, recommendations regarding the prescription of gastroprotective agents (GPA
Adverse drug reactions in a primary care population prescribed non-steroidal anti-inflammatory drugs
Autor:
Sita M A Bierma-Zeinstra, Johan van der Lei, Geert W. ‘t Jong, Miriam C. J. M. Sturkenboom, Aafke R Koffeman, Pim A J Luijsterburg, Amanda R. Van Buul, Vera E. Valkhoff, Patrick J E Bindels
Publikováno v:
Scandinavian Journal of Primary Health Care, 33(3), 163-169. Informa Healthcare
Scandinavian Journal of Primary Health Care
Scandinavian Journal of Primary Health Care
Objective. To determine how often patients with musculoskeletal (MSK) complaints prescribed a non-steroidal anti-inflammatory drug (NSAID) subsequently consult their general practitioner (GP) with a non-serious adverse drug reaction (ADR). Design. Co
Autor:
Patrick J E Bindels, Johan van der Lei, Geert W't Jong, Sevde Celik, Miriam C. J. M. Sturkenboom, Pim A J Luijsterburg, Aafke R Koffeman, Sita M A Bierma-Zeinstra, Vera E. Valkhoff
Publikováno v:
British Journal of General Practice, 64(621), E191-E198. Royal College of General Practitioners
Background The use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with serious adverse drug events (ADEs). Aim To determine the prevalence of over-the-counter (OTC) NSAID use in the general population and in patients with a high risk
Autor:
Miriam C. J. M. Sturkenboom, Aafke R Koffeman, Margaretha F. Warlé-van Herwaarden, Peter A. G. M. De Smet, Geert W. ‘t Jong, Vera E. Valkhoff, Martina Teichert
Publikováno v:
Expert Opinion on Drug Safety, 13, 2, pp. 157-65
Expert Opinion on Drug Safety, 13(2), 157-165. Taylor & Francis Ltd
Expert Opinion on Drug Safety, 13, 157-65
Expert Opinion on Drug Safety, 13(2), 157-165. Taylor & Francis Ltd
Expert Opinion on Drug Safety, 13, 157-65
Contains fulltext : 127746.pdf (Publisher’s version ) (Closed access) OBJECTIVE: The Dutch HARM-Wrestling (HW) Task Force issued general and drug-specific recommendations aimed at reducing hospital admissions related to medication (HARMs). This stu
Autor:
Sita M A Bierma-Zeinstra, Margreet F Warlé-van Herwaarden, Patrick J E Bindels, Geert W't Jong, Miriam C. J. M. Sturkenboom, Pim A J Luijsterburg, Vera E. Valkhoff, Aafke R Koffeman
Publikováno v:
Scandinavian Journal of Primary Health Care, 32, 2, pp. 90-8
Scandinavian Journal of Primary Health Care, 32(2), 90-98. Informa Healthcare
Scandinavian Journal of Primary Health Care, 32, 90-8
Scandinavian Journal of Primary Health Care
Scandinavian Journal of Primary Health Care, 32(2), 90-98. Informa Healthcare
Scandinavian Journal of Primary Health Care, 32, 90-8
Scandinavian Journal of Primary Health Care
Contains fulltext : 138369.pdf (Publisher’s version ) (Open Access) OBJECTIVE: To determine the influence of ischaemic cardiovascular (CV) risk on prescription of non-steroidal anti-inflammatory drugs (NSAIDs) by general practitioners (GPs) in pati
Autor:
Aafke R Koffeman, Patrick J E Bindels, Marc A. Koopmanschap, Pim A J Luijsterburg, Sita M A Bierma-Zeinstra, D. Schiphof, Jacoline J van den Driest
Publikováno v:
BMJ Open, 7(9):e018661. BMJ Publishing Group
BMJ Open
BMJ Open
IntroductionOsteoarthritis (OA) is a highly prevalent painful condition of the musculoskeletal system. The effectiveness of current analgesic options has proven to be limited and improved analgesic treatment is needed. Several randomised placebo-cont
Autor:
Aafke R Koffeman, Geert W. ‘t Jong, Miriam C. J. M. Sturkenboom, Sita M A Bierma-Zeinstra, Pim A J Luijsterburg, Patrick J E Bindels, M. Warlé-van Herwaarden, Vera E. Valkhoff
Publikováno v:
Annals of the Rheumatic Diseases. 71:118.1-118
Background To reduce adverse drug events (ADEs), clinical guidelines recommend cautious prescription of non-steroidal anti-inflammatory drugs (NSAIDs) in patients known to be at a high risk of developing a serious ADE. General practitioners (GPs) fre